Cardiovascular Effects of Fluoxetine in Depressed Patients With Heart Disease

1998 ◽  
Vol 155 (5) ◽  
pp. 660-665 ◽  
Author(s):  
Steven P. Roose ◽  
Alexander H. Glassman ◽  
Evelyn Attia ◽  
Sally Woodring ◽  
Elsa-Grace V. Giardina ◽  
...  
Keyword(s):  
Heart Disease ◽  
Cardiovascular Effects ◽  
Depressed Patients

Cardiovascular Effects of Tricyclic Antidepressants in Depressed Patients with Chronic Heart Disease

1982 ◽  
Vol 306 (16) ◽  
pp. 954-959 ◽  
Author(s):  
Richard C. Veith ◽  
Murray A. Raskind ◽  
James H. Caldwell ◽  
Robert F. Barnes ◽  
Gail Gumbrecht ◽  
...  
Keyword(s):  
Heart Disease ◽  
Tricyclic Antidepressants ◽  
Cardiovascular Effects ◽  
Depressed Patients ◽  
Chronic Heart Disease

Radiation-induced heart disease: surveillance and management

ESC CardioMed ◽  
2018 ◽  
pp. 1153-1156
Author(s):  
Ersilia M. DeFilippis ◽  
Anju Nohria
Keyword(s):  
Heart Disease ◽  
Disease Surveillance ◽  
Cardiovascular Effects ◽  
Pericardial Disease ◽  
Long Term Follow Up ◽  
Radiation Induced ◽  
Artery Disease ◽  
Effects Of Radiation

Radiation-induced heart disease is a major cause of morbidity and mortality among cancer survivors. It encompasses many clinical entities, including pericardial disease, coronary artery disease, valvular disease, cardiomyopathy, conduction system abnormalities, autonomic dysfunction, and peripheral vascular disease. As the cardiovascular effects of radiation manifest many years after treatment, long-term follow-up with regular screening is essential. This chapter reviews the epidemiology and pathogenesis of radiation-induced heart disease as well as existing consensus recommendations regarding surveillance and management.

Elevated platelet factor 4 and β-thromboglobulin plasma levels in depressed patients with ischemic heart disease

1997 ◽  
Vol 42 (4) ◽  
pp. 290-295 ◽  
Author(s):  
Fouzia Laghrissi-Thode ◽  
William R. Wagner ◽  
Bruce G. Pollock ◽  
Peter C. Johnson ◽  
Mitchell S. Finkel
Keyword(s):  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Plasma Levels ◽  
Platelet Factor 4 ◽  
Ischemic Heart ◽  
Platelet Factor ◽  
Depressed Patients

Cardiovascular Effects of Endothelin

Physiology ◽  
1997 ◽  
Vol 12 (3) ◽  
pp. 113-117
Author(s):  
JD Grossman ◽  
JP Morgan
Keyword(s):  
Endothelial Cells ◽  
Heart Disease ◽  
Vascular Endothelial Cells ◽  
Cardiovascular Effects ◽  
Multiple Organ ◽  
Vascular Endothelial ◽  
Cellular Calcium ◽  
Organ Systems

Endothelin is a potent vasoconstricting agent released by vascular endothelial cells. Endothelin affects multiple organ systems and occurs at high levels with heart disease. Changes in cellular calcium levels and Ca2+ sensitization of myofilaments mediate the endothelin pathway. The ability to modulate endothelin levels may lead to many effective therapies.

Sign in / Sign up

Export Citation Format

Share Document